Urinary dicarboxylic acids in patients receiving lithium or rubidium salts

Area of Science:

• Biochemistry
• Nephrology
• Pharmacology

Background:

• Lithium is used therapeutically, but its metabolic effects require further elucidation.
• Understanding the renal and metabolic impact of lithium and rubidium salts is crucial for patient safety and therapeutic efficacy.

Purpose of the Study:

• To investigate the effects of therapeutic doses of lithium and rubidium salts on urinary and blood organic acid levels.
• To explore the potential mechanisms, including renal transport and intermediary metabolism, underlying these effects.

Main Methods:

• Four subjects received therapeutic doses of lithium salts under controlled dietary conditions.
• Urinary and blood samples were analyzed for organic acid concentrations, including dicarboxylic acids and 2-oxoglutarate.

Main Results:

• Lithium administration led to a fivefold increase in urinary output of certain dicarboxylic acids.
• Rubidium salts increased both urinary and blood levels of 2-oxoglutarate.
• Observed changes suggest a direct effect on renal transport for lithium and on intermediary metabolism for rubidium.

Conclusions:

• Lithium salts impact renal handling of dicarboxylic acids.
• Rubidium salts appear to influence intermediary metabolism, specifically affecting 2-oxoglutarate.
• These findings highlight distinct metabolic and renal effects of lithium and rubidium, warranting further investigation into their mechanisms.